查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403410

2030 年胃肠支架市场预测：按产品类型、材料、应用、最终用户和地区分類的全球分析

Gastrointestinal Stents Market Forecasts to 2030 - Global Analysis By Product, Type, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球胃肠支架市场规模为5.2971亿美元，预计到2030年将达到8.8456亿美元，预测期内复合年增长率为7.6%。

胃肠支架是医疗设备，用于治疗消化器官系统内狭窄或阻塞的通道，例如食道、胃或肠。这些管状结构透过内视镜插入，以提供支撑、缓解阻塞并促进液体和食物的流动。胃肠支架在治疗狭窄、肿瘤和阻塞等疾病方面发挥重要作用，为手术提供了一种侵入性较小的替代方案。

根据 MDPI Publishers 在《Current Oncology Research Article》上发表的 2022 年报告显示，中国报告的上消化道癌症病例数为男性 14,934,040 例，女性 6,262,431 例，1990 年至 2019 年增长率为 181.4%。

胃肠道疾病盛行率增加

由于大肠直肠癌、发炎性肠道疾病疾病和胃肠道狭窄等胃肠道疾病的盛行率不断增加，需要有效的治疗性介入，而胃肠道支架可以缓解患者的症状，在改善预后方面发挥着重要作用。这些支架有助于恢復正常的消化功能、缓解症状并提供微创解决方案。人们对这些疾病的认识不断提高，加上支架技术的进步，医疗保健专业人员越来越倾向于选择这些设备来满足胃肠道干预需求的激增，从而进一步推动市场增长。我是。

缺乏意识

对胃肠道问题和可用治疗方案缺乏认识可能会导致诊断和治疗的延迟。患者教育以及医疗保健提供者和患者之间的共同决策可能会受到共用，从而限制了胃肠道疾病管理的选择。从市场角度来看，如果医疗保健专业人士和公众的意识不足，製造商和供应商在促销产品和增加市场占有率可能会面临挑战。

客製化和针对患者的解决方案的兴起

客製化胃肠道支架以满足患者的个别需求可以提高治疗效果并最大限度地减少潜在的併发症。这一趋势不仅解决了独特的解剖学差异，而且改善了患者的整体治疗效果并促进了市场的创新和成长。随着个体化医疗介入的需求不断上升，胃肠支架领域个体化解决方案的整合被定位为进步和市场拓展的关键手段。

替代治疗方案的可用性

患者和医疗保健提供者可以选择支架以外的干预措施，例如药物治疗或微创手术，从而减少对胃肠道支架的需求。这些不断变化的偏好可能会影响传统支架製造商的市场占有率和收益潜力，需要创新、功效和其他因素才能在不断发展的胃肠道治疗领域保持竞争力，强调需要改进和策略差异化。

COVID-19 的影响

COVID-19 大流行造成供应链中断、选择性手术延迟以及危机管理医疗资源的转移，从而影响了胃肠支架市场。这些因素导致胃肠支架需求暂时下降。然而，随着医疗保健系统适应新的常态和选择性手术的恢復，市场正在復苏。对内视镜手术的日益关注和支架技术的进步也将推动胃肠支架市场的未来成长。

自膨胀金属支架市场预计将在预测期内成为最大的市场

自膨胀金属支架领域预计将出现良好的成长。自膨式金属支架（SEMS）在胃肠道支架中发挥至关重要的作用，为多种病症提供微创解决方案。这些支架由金属合金製成，在展开时自动膨胀，为阻塞或狭窄的胃肠道提供结构支撑。 SEMS 可有效缓解阻塞和狭窄等症状，进而改善消化功能。其多功能性和适应性使其成为治疗食道、结直肠和胆道阻塞等疾病的首选。

胃肠癌领域预计在预测期内复合年增长率最高

预计胃肠癌领域在预测期内复合年增长率最高。胃肠支架透过缓解症状和改善患者的生活品质在胃肠道癌症的治疗中发挥重要作用。这些支架透过内视镜手术进行部署，提供了一种微创解决方案，可恢復正常功能并允许食物和液体通过。胃肠支架起到安宁疗护的作用，提高患者的舒适度并促进治疗计划。

占比最大的地区：

由于胃肠道疾病的发病率增加和人口老化，预计亚太地区在预测期内将占据最大的市场占有率。中国、日本和印度等国家对市场成长做出了巨大贡献。它也是波士顿、美敦力和雅培实验室等主要企业的所在地。对微创手术的需求以及大肠直肠癌等疾病的日益普及正在刺激该地区采用胃肠支架。随着医疗基础设施的改善和对有效胃肠道介入的需求的增加，预计该市场将继续扩大。

复合年增长率最高的地区：

由于阻塞性胃肠道疾病的盛行率不断增加、有利的报销政策和人口老化，预计北美在预测期内将出现最高的复合年增长率。北美是医疗设备产业最发达的市场之一。此外，由于能够以低廉的价格提供先进的医疗服务，该地区的医疗旅游业正在蓬勃发展，并且该地区的患者群体预计将扩大。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胃肠支架市场：依产品

  • 十二指肠支架
  • 胆管支架
  • 胰臟支架
  • 结肠支架
  • 食道支架

第六章全球胃肠支架市场：依类型

  • 抗迁移支架
  • 放射性支架
  • 药物释放型支架
  • 抗逆流支架
  • 重塑支架
  • 其他类型

第七章全球胃肠支架市场：依材料分类

  • 自膨胀金属支架
  • 塑胶支架
  • 其他材料

第八章全球胃肠支架市场：依应用分类

  • 胃癌
  • 大肠激躁症
  • 胰臟癌
  • 大肠直肠癌
  • 消化道癌症
  • 食道癌
  • 胆道疾病
  • 其他用途

第九章全球胃肠支架市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第十章全球胃肠支架市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Boston Scientific Corporation
  • Hobbs Medical Inc.
  • General Electric Company
  • Cantel Medical Corporation
  • Olympus Corporation
  • Merit Medical Systems
  • Qualimed
  • Medtronic
  • Conmed Corporation
  • Terumo Corporation
  • Johnson & Johnson
  • The 3M Company
  • Smith & Nephew
  • Diagmed Healthcare
  • Medline Industries
  • Baxter
  • B. Braun Melsungen AG
  • Danaher Corporation
Product Code: SMRC24635

According to Stratistics MRC, the Global Gastrointestinal Stents Market is accounted for $529.71 million in 2023 and is expected to reach $884.56 million by 2030 growing at a CAGR of 7.6% during the forecast period. Gastrointestinal stents are medical devices used to treat narrowed or blocked passages within the digestive system, such as the esophagus, stomach, or intestines. These tubular structures are inserted endoscopically to provide support, relieve obstruction, and facilitate the flow of fluids or food. Gastrointestinal stents play a crucial role in managing conditions like strictures, tumours, or obstructions, offering a minimally invasive alternative to surgery.

According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.

Market Dynamics:

Driver:

Increasing prevalence of gastrointestinal disorders

The escalating prevalence of gastrointestinal disorders, such as colorectal cancer, inflammatory bowel disease, and gastrointestinal strictures necessitates effective therapeutic interventions, where gastrointestinal stents play a crucial role in providing relief and improving patient outcomes. These stents facilitate the restoration of normal digestive function, alleviate symptoms, and offer minimally invasive solutions. The growing awareness of these disorders, coupled with advancements in stent technologies, further propels market growth as healthcare professionals increasingly opt for these devices to address the surging demand for gastrointestinal interventions.

Restraint:

Lack of awareness

Lack of awareness about gastrointestinal issues and available treatment options may lead to delayed diagnosis and treatment. It can hinder patient education and shared decision-making between healthcare providers and patients, limiting the choices available for managing gastrointestinal conditions. From a market perspective, manufacturers and suppliers may face challenges in promoting their products and expanding their market share if there is insufficient awareness among both healthcare professionals and the general public.

Opportunity:

Rising customized & patient-specific solutions

Tailoring gastrointestinal stents to individual patient needs enhances treatment efficacy and minimizes potential complications. This trend not only addresses unique anatomical variations but also improves overall patient outcomes, driving innovation and growth within the market. As demand for personalized medical interventions continues to rise, the integration of customized solutions in the gastrointestinal stents sector positions itself as a key avenue for advancement and market expansion.

Threat:

Availability of alternative treatment options

Patients and healthcare providers may opt for non-stent interventions, such as medications or minimally invasive procedures, reducing the demand for gastrointestinal stents. This shift in preferences could impact the market share and revenue potential for traditional stent manufacturers, emphasizing the need for innovation, improved efficacy, and strategic differentiation to maintain a competitive edge in the evolving landscape of gastrointestinal treatments.

COVID-19 Impact

The COVID-19 pandemic has impacted the Gastrointestinal Stents Market by causing disruptions in the supply chain, delaying elective procedures, and diverting healthcare resources to manage the crisis. These factors have led to a temporary decline in the demand for gastrointestinal stents. However, as healthcare systems adapt to the new normal and elective procedures resume, the market has recovered. The increased focus on endoscopic procedures and advancements in stent technology also drive future growth in the gastrointestinal stents market.

The self-expanding metal stents segment is expected to be the largest during the forecast period

The self-expanding metal stents segment is estimated to have a lucrative growth. Self-expanding metal stents (SEMS) play a pivotal role in Gastrointestinal Stents, offering a minimally invasive solution for various conditions. Composed of metal alloys, these stents automatically expand upon deployment, providing structural support to obstructed or narrowed gastrointestinal passages. SEMS effectively alleviate symptoms, such as blockages or strictures, enabling improved digestive function. Their versatility and adaptability make them a preferred choice for treating conditions like esophageal, colorectal, and biliary obstructions.

The gastrointestinal cancers segment is expected to have the highest CAGR during the forecast period

The gastrointestinal cancers segment is anticipated to witness the highest CAGR growth during the forecast period. Gastrointestinal stents play a crucial role in managing gastrointestinal cancers by alleviating symptoms and improving the quality of life for patients. Deployed through endoscopic procedures, these stents provide a minimally invasive solution, restoring proper functioning and enabling the passage of food and fluids. Gastrointestinal stents serve as palliative care, enhancing patient comfort and facilitating treatment plans.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising gastrointestinal disorders and an aging population. Countries like China, Japan, and India are prominent contributors to the market's growth. It is home for major key players such as Boston, Medtronic and Abbott Laboratories. The demand for minimally invasive procedures and a growing prevalence of diseases such as colorectal cancer are fueling the adoption of gastrointestinal stents in the region. The market is poised for continued expansion as healthcare infrastructure improves and the need for effective gastrointestinal interventions rises.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of obstructive gastrointestinal diseases, favourable reimbursement policies and aging population. North America is one of the most developed medical device industries market. Further, the booming medical tourism industry in the region owing to availability of the advanced medical treatments at a cheaper cost is anticipated to expand the patient base in the region.

Key players in the market:

Some of the key players profiled in the Gastrointestinal Stents Market include Boston Scientific Corporation, Hobbs Medical Inc., General Electric Company, Cantel Medical Corporation, Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson, The 3M Company, Smith & Nephew, Diagmed Healthcare, Medline Industries, Baxter, B. Braun Melsungen AG and Danaher Corporation.

Key Developments:

In November 2020, Boston Scientific Corporation (US) has received 510(k) approval from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by esophageal cancer.

In October 2020, Olympus Corporation (Japan) launched HANAROSTENT Esophagus TTS Self-expanding Metal Stents (SEMS) made by MI-Tech and distributed exclusively through Olympus in the US.

Products Covered:

  • Duodenal Stent
  • Biliary Stent
  • Pancreatic Stent
  • Colonic Stent
  • Esophageal Stent

Types Covered:

  • Anti-Migratory Stents
  • Radioactive Stents
  • Drug-Eluting Stents
  • Anti-Reflux Stents
  • Shape-Modified Stents
  • Other Types

Materials Covered:

  • Self-Expanding Metal Stents
  • Plastic Stents
  • Other Materials

Applications Covered:

  • Stomach Cancer
  • Irritable Bowel Syndrome
  • Pancreatic Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancers
  • Esophageal Cancer
  • Biliary Diseases
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gastrointestinal Stents Market, By Product

  • 5.1 Introduction
  • 5.2 Duodenal Stent
  • 5.3 Biliary Stent
  • 5.4 Pancreatic Stent
  • 5.5 Colonic Stent
  • 5.6 Esophageal Stent

6 Global Gastrointestinal Stents Market, By Type

  • 6.1 Introduction
  • 6.2 Anti-Migratory Stents
  • 6.3 Radioactive Stents
  • 6.4 Drug-Eluting Stents
  • 6.5 Anti-Reflux Stents
  • 6.6 Shape-Modified Stents
  • 6.7 Other Types

7 Global Gastrointestinal Stents Market, By Material

  • 7.1 Introduction
  • 7.2 Self-Expanding Metal Stents
  • 7.3 Plastic Stents
  • 7.4 Other Materials

8 Global Gastrointestinal Stents Market, By Application

  • 8.1 Introduction
  • 8.2 Stomach Cancer
  • 8.3 Irritable Bowel Syndrome
  • 8.4 Pancreatic Cancer
  • 8.5 Colorectal Cancer
  • 8.6 Gastrointestinal Cancers
  • 8.7 Esophageal Cancer
  • 8.8 Biliary Diseases
  • 8.9 Other Applications

9 Global Gastrointestinal Stents Market, By End User

  • 9.1 Introduction
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Hospitals
  • 9.4 Specialty Clinics

10 Global Gastrointestinal Stents Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific Corporation
  • 12.2 Hobbs Medical Inc.
  • 12.3 General Electric Company
  • 12.4 Cantel Medical Corporation
  • 12.5 Olympus Corporation
  • 12.6 Merit Medical Systems
  • 12.7 Qualimed
  • 12.8 Medtronic
  • 12.9 Conmed Corporation
  • 12.10 Terumo Corporation
  • 12.11 Johnson & Johnson
  • 12.12 The 3M Company
  • 12.13 Smith & Nephew
  • 12.14 Diagmed Healthcare
  • 12.15 Medline Industries
  • 12.16 Baxter
  • 12.17 B. Braun Melsungen AG
  • 12.18 Danaher Corporation

List of Tables

  • Table 1 Global Gastrointestinal Stents Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gastrointestinal Stents Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Gastrointestinal Stents Market Outlook, By Duodenal Stent (2021-2030) ($MN)
  • Table 4 Global Gastrointestinal Stents Market Outlook, By Biliary Stent (2021-2030) ($MN)
  • Table 5 Global Gastrointestinal Stents Market Outlook, By Pancreatic Stent (2021-2030) ($MN)
  • Table 6 Global Gastrointestinal Stents Market Outlook, By Colonic Stent (2021-2030) ($MN)
  • Table 7 Global Gastrointestinal Stents Market Outlook, By Esophageal Stent (2021-2030) ($MN)
  • Table 8 Global Gastrointestinal Stents Market Outlook, By Type (2021-2030) ($MN)
  • Table 9 Global Gastrointestinal Stents Market Outlook, By Anti-Migratory Stents (2021-2030) ($MN)
  • Table 10 Global Gastrointestinal Stents Market Outlook, By Radioactive Stents (2021-2030) ($MN)
  • Table 10 Global Gastrointestinal Stents Market Outlook, By Drug-Eluting Stents (2021-2030) ($MN)
  • Table 12 Global Gastrointestinal Stents Market Outlook, By Anti-Reflux Stents (2021-2030) ($MN)
  • Table 13 Global Gastrointestinal Stents Market Outlook, By Shape-Modified Stents (2021-2030) ($MN)
  • Table 14 Global Gastrointestinal Stents Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 15 Global Gastrointestinal Stents Market Outlook, By Material (2021-2030) ($MN)
  • Table 16 Global Gastrointestinal Stents Market Outlook, By Self-Expanding Metal Stents (2021-2030) ($MN)
  • Table 17 Global Gastrointestinal Stents Market Outlook, By Plastic Stents (2021-2030) ($MN)
  • Table 18 Global Gastrointestinal Stents Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 19 Global Gastrointestinal Stents Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 Global Gastrointestinal Stents Market Outlook, By Stomach Cancer (2021-2030) ($MN)
  • Table 21 Global Gastrointestinal Stents Market Outlook, By Irritable Bowel Syndrome (2021-2030) ($MN)
  • Table 22 Global Gastrointestinal Stents Market Outlook, By Pancreatic Cancer (2021-2030) ($MN)
  • Table 23 Global Gastrointestinal Stents Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
  • Table 24 Global Gastrointestinal Stents Market Outlook, By Gastrointestinal Cancers (2021-2030) ($MN)
  • Table 25 Global Gastrointestinal Stents Market Outlook, By Esophageal Cancer (2021-2030) ($MN)
  • Table 26 Global Gastrointestinal Stents Market Outlook, By Biliary Diseases (2021-2030) ($MN)
  • Table 27 Global Gastrointestinal Stents Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Gastrointestinal Stents Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Gastrointestinal Stents Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 30 Global Gastrointestinal Stents Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 31 Global Gastrointestinal Stents Market Outlook, By Specialty Clinics (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.